-+ 0.00%
-+ 0.00%
-+ 0.00%

MapLight Therapeutics Q4 EPS $(2.47) Misses $(0.96) Estimate

Benzinga·03/26/2026 11:07:14
Listen to the news
MapLight Therapeutics (NASDAQ:MPLT) reported quarterly losses of $(2.47) per share which missed the analyst consensus estimate of $(0.96) by 156.49 percent. This is a 91.16 percent increase over losses of $(27.95) per share from the same period last year.